EIF2AK3 and rhabdomyosarcoma: As noted, IRE1 and PERK signaling are critical for RMS cell survival, with IRE1 inhibitor MKC8866 and PERK inhibitor AMGEN44 inducing senescence in rhabdomyosarcoma cells to curb proliferation.